Abstract | OBJECTIVES: METHODS: Patients with prostatitis refractory to at least 8 weeks of routine therapy and with urinalysis positive for microhematuria were considered for the present study. In addition to their prior therapy, the patients received carbazochrome at a dose of 30 mg three times a day. The severity of pain (score 0-10), daytime and night-time frequency, international prostate symptom score, global self-assessment, urine occult blood positivity, and adverse events were assessed after 4 and 8 weeks of treatment, and compared with baseline findings. RESULTS: A total of 50 patients (mean age 68.6 ± 8.5 years) were evaluable. The pain score decreased significantly from 3.2 ± 2.1 at baseline to 1.7 ± 1.4 after 4 weeks of treatment and to 1.1 ± 1.8 after 8 weeks. Daytime and night-time frequency, storage symptoms, post-micturition symptoms, and urine occult blood positivity also significantly improved. More than 36% of the patients gave a global self-assessment rating of "improved" or "better" after both 4 and 8 weeks of treatment. Mild adverse events occurred in three patients; one had nausea and two developed drug rash. CONCLUSIONS:
Carbazochrome seems to effectively improve pain as well as storage and post-micturition symptoms in patients with refractory chronic prostatitis.
|
Authors | Hitoshi Oh-oka, Tetsuo Yamada, Hiromitsu Noto, Tomokazu Umeyama, Katsumi Kadekawa, Katsuhiro Ashitomi, Saori Nishijima, Kimio Sugaya |
Journal | International journal of urology : official journal of the Japanese Urological Association
(Int J Urol)
Vol. 21
Issue 11
Pg. 1162-6
(Nov 2014)
ISSN: 1442-2042 [Electronic] Australia |
PMID | 24964194
(Publication Type: Clinical Trial, Journal Article, Multicenter Study)
|
Copyright | © 2014 The Japanese Urological Association. |
Chemical References |
- Hemostatics
- Adrenochrome
- carbazochrome
|
Topics |
- Adrenochrome
(analogs & derivatives, therapeutic use)
- Aged
- Chronic Disease
- Hemostatics
(therapeutic use)
- Humans
- Male
- Middle Aged
- Prostatitis
(drug therapy)
- Treatment Outcome
|